Skip to the content
November 17, 2025
edhardyshirts
A Family Of Learning
  • School
  • University
  • Home School
  • Online course
  • Science
  • Career
  • About Us
    • Advertise Here
    • Contact Us
    • Privacy Policy
    • Sitemap
Excess Iron Linked With COPD Exacerbation
Free Study

Excess Iron Linked With COPD Exacerbation

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations.A new report yielded fresh insights into the role of pulmonary...

Reinold Sinaga
January 19, 2022
Read More
How to Order Free At-Home COVID-19 Tests from the Government
Free Study

How to Order Free At-Home COVID-19 Tests from the Government

Starting Jan. 18, Americans will be able to order free at-home COVID-19 test kits from the government, in the Biden Administration's ongoing effort to curb...

Reinold Sinaga
January 19, 2022
Read More
Evidence of free tropospheric and long-range transport of microplastic at Pic du Midi Observatory
Free Study

Evidence of free tropospheric and long-range transport of microplastic at Pic du Midi Observatory

Atmospheric MP found at PDMMP samples were collected between June 23, 2017 and October 23, 2017 (15 × 7 day durations). MP fragments or fibres were found...

Reinold Sinaga
January 19, 2022
Read More
Relatlimab, Nivolumab Improve Progression-Free Survival in Metastatic Melanoma
Free Study

Relatlimab, Nivolumab Improve Progression-Free Survival in Metastatic Melanoma

The FDA granted priority review to the combination of relatlimab and nivolumab in September 2021 based on the results of this study.The combination of relatlimab...

Reinold Sinaga
January 19, 2022
Read More
BTK Inhibitors Continue to Offer Chemotherapy-Free Options for MCL Treatment
Free Study

BTK Inhibitors Continue to Offer Chemotherapy-Free Options for MCL Treatment

The use of Bruton’s tyrosine kinase (BTK) inhibitors have grown dramatically in the field of mantle cell lymphoma (MCL), providing a chemotherapy-free option for many...

Reinold Sinaga
January 19, 2022
Read More
Pembrolizumab Shows Improvements in Disease-Free Survival as Adjuvant Treatment for Non-Small Cell Lung Cancer
Free Study

Pembrolizumab Shows Improvements in Disease-Free Survival as Adjuvant Treatment for Non-Small Cell Lung Cancer

The findings from the phase 3 KEYNOTE-091 trial mark the first positive study for pembrolizumab in adjuvant stage IB-IIIA non-small cell lung cancer.New study results...

Reinold Sinaga
January 19, 2022
Read More

Posts pagination

Previous 1 … 4 5 6 Next
  • School
  • University
  • Home School
  • Online course
  • Science
  • Career
  • About Us
    • Advertise Here
    • Contact Us
    • Privacy Policy
    • Sitemap